Literature DB >> 3105563

A case of heterozygous Fabry's disease with a short PR interval and giant negative T waves.

A Yokoyama, M Yamazoe, A Shibata.   

Abstract

A 55 year old woman with heterozygous Fabry's disease presented with cardiac symptoms. The electrocardiogram showed a PR interval of 0.12 s and giant negative T waves, suggesting apical hypertrophic cardiomyopathy. Endomyocardial biopsy, however, revealed myelin like substances characteristic of Fabry's disease. Increasing thickness of the left ventricular wall was seen by echocardiography over a period of five years. A deficiency of alpha galactosidase activity in the leucocytes confirmed the diagnosis of Fabry's disease, although this patient had neither angiokeratoma or proteinuria. The possibility of Fabry's disease should be considered in patients with cardiomegaly of unknown cause and the following electrocardiographic abnormalities: a PR interval less than or equal to 0.12 s, high voltage QRS complexes in the left precordial leads, and giant negative T waves.

Entities:  

Mesh:

Year:  1987        PMID: 3105563      PMCID: PMC1216430          DOI: 10.1136/hrt.57.3.296

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  12 in total

Review 1.  Enzymic diagnosis of sphingolipidoses.

Authors:  K Suzuki
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

2.  [Differential staining of epon-resin-embedded tissue for light microscopy observation (including review of the literature on general technics of semi-thin sectioning)].

Authors:  M Kurotaki
Journal:  Kaibogaku Zasshi       Date:  1972-06

3.  Cardiac manifestations of Fabry's disease. Report of a case with pulmonary regurgitation diagnosed on the basis of endomyocardial biopsy findings.

Authors:  S Matsui; E Murakami; N Takekoshi; Y Hiramaru; T Kin
Journal:  Jpn Circ J       Date:  1977-09

4.  Informed consent.

Authors:  J F Toole
Journal:  Circulation       Date:  1973-07       Impact factor: 29.690

5.  Genetic inactivation of the alpha-galactosidase locus in carriers of Fabry's disease.

Authors:  G Romeo; B R Migeon
Journal:  Science       Date:  1970-10-09       Impact factor: 47.728

6.  Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients.

Authors:  H Yamaguchi; T Ishimura; S Nishiyama; F Nagasaki; S Nakanishi; F Takatsu; T Nishijo; T Umeda; K Machii
Journal:  Am J Cardiol       Date:  1979-09       Impact factor: 2.778

7.  Angiokeratoma corporis diffusum universale (Fabry's disease) in female subjects.

Authors:  C D Burda; P R Winder
Journal:  Am J Med       Date:  1967-02       Impact factor: 4.965

8.  Gene action in the X-chromosome of the mouse (Mus musculus L.).

Authors:  M F LYON
Journal:  Nature       Date:  1961-04-22       Impact factor: 49.962

9.  Fabry cardiomyopathy in the female confirmed by endomyocardial biopsy.

Authors:  J C Broadbent; W D Edwards; H Gordon; G O Hartzler; J E Krawisz
Journal:  Mayo Clin Proc       Date:  1981-10       Impact factor: 7.616

10.  Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study.

Authors:  T Sakamoto; C Tei; M Murayama; H Ichiyasu; Y Hada
Journal:  Jpn Heart J       Date:  1976-09
View more
  3 in total

1.  Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy.

Authors:  M Elleder; V Bradová; F Smíd; M Budĕsínský; K Harzer; B Kustermann-Kuhn; J Ledvinová; V Král; V Dorazilová
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 2.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

3.  Cardiac-specific over-expression of epidermal growth factor receptor 2 (ErbB2) induces pro-survival pathways and hypertrophic cardiomyopathy in mice.

Authors:  Polina Sysa-Shah; Yi Xu; Xin Guo; Frances Belmonte; Byunghak Kang; Djahida Bedja; Scott Pin; Noriko Tsuchiya; Kathleen Gabrielson
Journal:  PLoS One       Date:  2012-08-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.